In the first quarter of 2021, NPO Microgen, being part of the management of the Nacimbio holding of Rostec State Corporation, increased exports of drug products to Uzbekistan by over 50 percent as compared to the same period of the last year. In kind, about 500 thousand packages of medicines were exported to the republic.
The key sales driver was drugs of the bacteriophages pharmacological group, registered in 2019 in the country. Their share was about 40% of the total sales. The greatest demand was for Sekstaphage, which has been supplied to Uzbekistan since 2018. In the first quarter of this year alone, its sales to the republic exceeded the entire annual sales volume of the drug in 2020 by 60%. Sekstaphage has a wide spectrum of antimicrobial action and is aimed at treatment and prevention of pyoinflammatory and enteral diseases caused by staphylococci, streptococci, Proteus, Klebsiella, Pseudomonas aeruginosa and Escherichia coli.
In addition, for the first time, wholesale deliveries of two types of bacteriophages - Intesti and Staphylococcal bacteriophage were organized in the republic - for the latter, a new, more convenient dosage form with a volume of 20 ml was registered in Uzbekistan last year.
“The Republic of Uzbekistan is a strategic partner for Microgen. Thanks to effective cooperation with local pharmaceutical distributors with the support of the state, over the past three years, the company has been able to increase both the list and the volume of products supplied to the republic. Currently, we ship to Uzbekistan about 40 titles of drugs, including such pharmacological groups as bacteriophages, vaccines and toxoids, as well as finished drug products used for the treatment of socially significant diseases: cardiovascular and many others,” Andrei Zagorsky, General Director of Nacimbio, the managing organization of Microgen, said.
In addition to bacteriophages, in 2021, a wholesale batch of Russian Botulinum toxin type A was exported to Uzbekistan for the first time, and supplies of allergens used for the treatment and prevention of allergic diseases were resumed.